🇺🇸 Duovent HFA in United States
18 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 18
Most-reported reactions
- Death — 3 reports (16.67%)
- Drug Interaction — 2 reports (11.11%)
- Dysuria — 2 reports (11.11%)
- Headache — 2 reports (11.11%)
- Metastases To Bone — 2 reports (11.11%)
- Priapism — 2 reports (11.11%)
- Pruritus — 2 reports (11.11%)
- Adrenal Gland Cancer — 1 report (5.56%)
- Anxiety — 1 report (5.56%)
- Apparent Death — 1 report (5.56%)
Other Respiratory/Pulmonology approved in United States
Frequently asked questions
Is Duovent HFA approved in United States?
Duovent HFA does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Duovent HFA in United States?
Centre Hospitalier Universitaire UCLouvain Namur is the originator. The local marketing authorisation holder may differ — check the official source linked above.